Dr. Sridhar P S highlights how Stereotactic Body Radiotherapy (SBRT) using CyberKnife technology promises better outcomes in treating Hepatocellular Carcinoma (HCC). The Cyberknife technology approach has renewed hopes in liver cancer patients.
Deaths due to Hepatocellular carcinoma (HCC) are increasing globally. It is the third most common cause of death worldwide. It is the fifth and seven most common cancer occurring in men and women respectively. Similarly, the incidence and mortality figures due to HCC caused by nonalcoholic fatty liver disease (NAFLD) are rising.
Dr. Sridhar P S, one of India’s leading radiation oncologists and an expert in CyberKnife Treatment states, ‘This remarkable technology has revolutionized treatment options to treat HCC. It enables precise and efficient delivery of radiation and hence has delivered better clinical outcomes and greatly improved the life of liver cancer patients.’
Dr. Sridhar P S is a senior radiation oncologist with more than 26 years of experience. He is an expert in IMRT, IGRT, SBRT, Tomo Therapy, and chemoradiotherapy which are used to treat prostate, hepatobiliary, pancreatic cancers, and benign and neurological tumors. He is associated with HCG Cancer Hospital, one of the best cancer hospitals in India, present in 21 locations in India.
Dr. Sridhar states that Hepatocellular carcinoma (HCC) occurs in patients with chronic liver diseases or cirrhosis due to hepatitis B or hepatitis C infection. It also occurs in patients diagnosed with nonalcoholic fatty liver disease, who are likely to suffer from obesity and diabetes mellitus.
Hepatocellular Carcinoma (HCC) cancer treatment involves surgical and non-surgical approaches. Along with surgical resections, chemotherapy, targeted immunotherapy, and Stereotactic Body Radiotherapy (SBRT) using CyberKnife technology has emerged as a reliable treatment with better outcomes and increased life expectancies.
The CyberKnife enables an unprecedented level of radiation dose, shaping and targeting precision, effectively bringing radiosurgical ablation capability to liver lesions while minimizing the risk of serious injury to normal hepatic parenchyma and adjacent tissues.
Dr Sridhar P S, an expert radiation oncologist who has treated HCC patients with SBRT using CyberKnife shares his experiences. He states that ‘Cyberknife is empowered with real-time imaging, advanced robotic and precision in delivery with sub-millimeter accuracy enables oncologists to treat cancer patients with high chances of better outcomes with zero or minimal trauma to the patients. ‘
He highlights the multiple advantages of SBRT with CyberKnife including a non-invasive approach, precision in the delivery of radiation
ensuring minimal damage to the surrounding healthy tissue, and fewer sessions. The precision targeting with sub-millimeter accuracy allows the radiation to be delivered to hard-to-reach areas in the body. SBRT with CyberKnife permits customized treatment suitable to each patient’s health and cancer stage for the best possible results.
About Dr. Sridhar P S
Dr. Sridhar P S is one of the most qualified radiation oncologists in India, with more than 26+ years of experience in IMRT, IGRT, Tomotherapy, SBRT, biotherapy and chemotherapy, targeted therapy, and other high-precision radiotherapy treatments. Dr. Sridhar P S has performed more than 3500 Cyberknife procedures and treated more than 3000 patients with radiation and critical cancer patients.
He is available for consultation at.
Phone Numbers: +91 90084 82284 / +91 98865 54972
- HCG – The Specialist in Cancer Care,
Tower-4, Room No. 219, 9/1, Kalinga Rao Rd, Sampangi Rama Nagar, Bengaluru, Karnataka.
Landmark: Near SCMI, Bangalore
- HCG ICS Khubchandani Cancer Centre,
31, Queens Barracks, Lady Ratan Tata Building, Maharshi Karve Rd, Cooperage, Mumbai, Maharashtra 400021
- HCG CCK Cancer Centre,
Shivachi Road, Parklands, Nairobi, Kenya